Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase III trial of EEC skin test for diagnosis of Mycobacterium tuberculosis infection in people aged 3 years and older
CTR20250169Phase 3Active
- Sponsor
- Kernal Biologics
- Start
- Aug 2025
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 3 trial of EEC in Tuberculosis (TB), sponsored by Kernal Biologics. Started Aug 2025; status: active.
02
Drugs
EEC
03
Conditions
Tuberculosis (TB)
Beyond the preview
Go deeper on CTR20250169.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20250169.